NIH-funded research R01 grant

Using focused ultrasound to enhance cancer immunotherapy

Official title: Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death

Funded at Van Andel Research Institute · NIH-11089435 · Data updated 2026-11-12

This study is looking at how a special ultrasound treatment can help the immune system spot and fight hard-to-detect cancers, like pancreatic cancer, by making the tumors more visible, which could lead to better results for patients.

More Ultrasound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVan Andel Research Institute
NIH-funded
Lab location1 site (Grand Rapids, United States)
Project startAugust 3, 2024
Project endMay 31, 2028
Funding year2025
Award (this year)$496,811
NIH project number5R01CA269394-04
Project IDNIH-11089435 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with cancers that are poorly recognized by the immune system, such as pancreatic cancer.

Less likely to help

Patients with cancers that are already effectively treated by existing immunotherapies may not benefit from this research.

What this research studies

This research investigates how focused ultrasound can be used to make certain cancers more recognizable to the immune system, particularly those that typically evade detection, like pancreatic cancer. By employing a technique called histotripsy, which non-invasively disrupts cancer cells, the study aims to trigger strong immune responses that could lead to the regression of tumors not directly treated. The approach focuses on understanding how this method can stimulate the immune system to attack cancer more effectively, potentially leading to improved outcomes for patients with hard-to-treat cancers.

Why it matters

Potential benefit: If successful, this research could significantly enhance the effectiveness of immunotherapy for patients with cancers that are currently difficult to treat.

How similar studies have gone: There is growing evidence that similar approaches using focused ultrasound have shown promise in enhancing immune responses against tumors.

Where this research is happening

  • Van Andel Research Institute
    Grand Rapids, United States
    Active

Researchers

  • Principal investigator: Cho, Clifford — Van Andel Research Institute
  • Study coordinator: Cho, Clifford

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.